Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy.
Front Oncol
; 12: 986236, 2022.
Article
in En
| MEDLINE
| ID: mdl-36212442
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Front Oncol
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
Switzerland